The Venture Codex Logo

The Venture Codex

Overview

Venture capital firm investing in early-stage technology and healthcare.

Founded

1981

Deals ยท 12mo

11

Stage focus

Series A
Series B
Series C

Geographic focus

Israel
United States

Sector focus

Enterprise Software
Financial Services
Venture Capital

Investment portfolio

248rounds
NAMEDATESIZE
HighLife
Sep 2026Participated
$92 MOther Equity
ReEmerge
Sep 2026Led
$37 MSeries A
Maneva
Jun 2026Led
$27 MSeries A
Cagent Vascular
May 2026Led
$41 MSeries D
Nervonik
Apr 2026Participated
$53 MSeries B
Route 92 Medical
Apr 2026Participated
$50 MOther Equity
Slang
Feb 2026Led
$36 MSeries B
Adaptive6
Jan 2026Led
$28 MSeries A
Okami Medical
Nov 2025Participated
$45 MOther Equity
Apono
Nov 2025Led
$34 MSeries B
Weave
Oct 2025Led
$20 MSeries A
Sparrow Pharmaceuticals
Sep 2025Participated
$95 MSeries B
HighLife
Sep 2026Participated
$92 MOther Equity
ReEmerge
Sep 2026Led
$37 MSeries A
Maneva
Jun 2026Led
$27 MSeries A
Cagent Vascular
May 2026Led
$41 MSeries D
Nervonik
Apr 2026Participated
$53 MSeries B
Route 92 Medical
Apr 2026Participated
$50 MOther Equity
Slang
Feb 2026Led
$36 MSeries B
Adaptive6
Jan 2026Led
$28 MSeries A
Okami Medical
Nov 2025Participated
$45 MOther Equity
Apono
Nov 2025Led
$34 MSeries B
Weave
Oct 2025Led
$20 MSeries A
Sparrow Pharmaceuticals
Sep 2025Participated
$95 MSeries B
248
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

U.S. Venture Partners: 248 funding rounds are recorded in the selected participation categories.All available history.
U.S. Venture Partners: 248 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed13
Series A3816
Series B2234
Series C+2059
Other Equity1045

Monthly Deal Activity

U.S. Venture Partners: 248 deals are recorded across 224 months.All available history.
U.S. Venture Partners: 248 deals are recorded across 224 months. All available history
MonthDeals
Mar '081
Apr '080
May '080
Jun '080
Jul '080
Aug '080
Sep '080
Oct '081
Nov '080
Dec '080
Jan '092
Feb '091
Mar '090
Apr '090
May '090
Jun '090
Jul '091
Aug '090
Sep '090
Oct '090
Nov '091
Dec '091
Jan '101
Feb '101
Mar '104
Apr '103
May '101
Jun '101
Jul '101
Aug '100
Sep '100
Oct '103
Nov '101
Dec '103
Jan '110
Feb '110
Mar '110
Apr '111
May '110
Jun '111
Jul '110
Aug '113
Sep '116
Oct '113
Nov '110
Dec '111
Jan '120
Feb '123
Mar '122
Apr '120
May '124
Jun '124
Jul '122
Aug '123
Sep '123
Oct '120
Nov '121
Dec '122
Jan '130
Feb '133
Mar '133
Apr '131
May '134
Jun '132
Jul '130
Aug '132
Sep '132
Oct '134
Nov '130
Dec '130
Jan '140
Feb '143
Mar '140
Apr '146
May '142
Jun '141
Jul '143
Aug '140
Sep '140
Oct '141
Nov '141
Dec '141
Jan '150
Feb '153
Mar '152
Apr '150
May '150
Jun '152
Jul '150
Aug '151
Sep '153
Oct '150
Nov '150
Dec '150
Jan '162
Feb '161
Mar '160
Apr '160
May '160
Jun '162
Jul '161
Aug '162
Sep '162
Oct '161
Nov '160
Dec '161
Jan '171
Feb '170
Mar '172
Apr '170
May '170
Jun '173
Jul '172
Aug '171
Sep '170
Oct '170
Nov '170
Dec '172
Jan '181
Feb '180
Mar '183
Apr '180
May '181
Jun '181
Jul '180
Aug '180
Sep '181
Oct '181
Nov '181
Dec '180
Jan '194
Feb '191
Mar '191
Apr '191
May '191
Jun '192
Jul '190
Aug '193
Sep '192
Oct '192
Nov '190
Dec '190
Jan '201
Feb '201
Mar '204
Apr '201
May '200
Jun '203
Jul '200
Aug '201
Sep '203
Oct '200
Nov '203
Dec '202
Jan '211
Feb '210
Mar '211
Apr '212
May '213
Jun '210
Jul '211
Aug '212
Sep '210
Oct '210
Nov '211
Dec '211
Jan '222
Feb '222
Mar '221
Apr '221
May '220
Jun '222
Jul '220
Aug '221
Sep '221
Oct '222
Nov '220
Dec '220
Jan '230
Feb '230
Mar '232
Apr '231
May '231
Jun '233
Jul '230
Aug '230
Sep '230
Oct '231
Nov '232
Dec '231
Jan '240
Feb '243
Mar '241
Apr '240
May '240
Jun '240
Jul '240
Aug '241
Sep '240
Oct '242
Nov '240
Dec '240
Jan '252
Feb '250
Mar '254
Apr '250
May '250
Jun '252
Jul '250
Aug '252
Sep '251
Oct '251
Nov '252
Dec '250
Jan '261
Feb '261
Mar '260
Apr '262
May '261
Jun '261
Jul '260
Aug '260
Sep '262
Oct '260

Sector Breakdown

U.S. Venture Partners: Health & Life Sciences is the largest displayed sector by deal count (94 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

U.S. Venture Partners: Health & Life Sciences is the largest displayed sector by deal count (94 deals). All available history
SectorDeals
Health & Life Sciences94
Enterprise Software91
Networks, Cloud & Communication68
Data, Analytics & IT35
Marketing & Advertising33
Cybersecurity & Privacy32
AI & Machine Learning26
Hardware & Robotics22
E-Commerce & Retail20
Manufacturing19
Media & Entertainment18
Fintech15
Consumer & Lifestyle12
Space & Frontier Tech10
Professional Services10
Social & Community Platforms9
Clean Energy & Sustainability7
Developer Tools7
Real Estate & Construction5
Transportation & Logistics5
Travel & Hospitality4
AR/VR3
Food & Agriculture2
Gaming & eSports1

Deal Size Distribution

U.S. Venture Partners: 248 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

U.S. Venture Partners: 248 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M17
$5M-$10M28
$10M-$25M101
$25M-$50M59
$50M-$100M36
$100M-$250M7
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

U.S. Venture Partners: United States has the largest recorded deal count among the displayed regions (221 deals).All available history.

Top 8 of 8 regions; European countries are grouped as Europe.

U.S. Venture Partners: United States has the largest recorded deal count among the displayed regions (221 deals). All available history
RegionDeals
United States221
Israel16
Europe4
Canada2
China2
L4b 3j61
208501
Pakistan1
U.S. Venture Partners: 20 co-investors are shown, with Norwest Venture Partners sharing 16 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

U.S. Venture Partners: Led accounts for 37% and participating for 63% of round participation.All available history.
U.S. Venture Partners: Led accounts for 37% and participating for 63% of round participation. All available history
CategoryDeals (count)Share (%)
Led9137%
Participating15763%
U.S. Venture Partners: Single-lead accounts for 71% and co-led for 29% of lead dynamics.All available history.
U.S. Venture Partners: Single-lead accounts for 71% and co-led for 29% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead6571%
Co-led2629%

Team

Casey Tansey

General Partner

Dafina Toncheva

General Partner

Jacques Benkoski

General Partner

Jonathan Root

General Partner

Rick Lewis

General Partner

Steve Krausz

General Partner